Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Agile Contraceptive Patches (AG200 Series)
NCT01250210Phase 2Completed
- Sponsor
- Agile Therapeutics
- Start
- Sep 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AG890, ethinyl estradiol in contraception, sponsored by Agile Therapeutics. Started Sep 2007; status: completed.
02
Drugs
AG890ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01250210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250210.